insights_auto
Why is AMGN34 up 3,16%?
Dive Deeperchevron_right
AMGN34:BVMF
Amgen Inc. BDR
74,02 R$
arrow_upward
+3,16%(+2,27) 1D
7 қаз., 13:18:15 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
73,64 R$
High
74,12 R$
Low
73,64 R$
Mkt. cap
223,12 млрд
Avg. vol.
412,00
Volume
50,00
52-wk high
83,06 R$
52-wk low
47,76 R$
Shares outstanding
540,63 млн
No. of employees
32 мың
Open
73,64 R$
High
74,12 R$
Low
73,64 R$
Mkt. cap
223,12 млрд
Avg. vol.
412,00
Volume
50,00
52-wk high
83,06 R$
52-wk low
47,76 R$
Shares outstanding
540,63 млн
No. of employees
32 мың
News stories
From web sources and news partners
MarketBeat
·
1 сағат бұрын
Worth Asset Management LLC Makes New $1.41 Million Investment in Amgen Inc. $AMGN
TradingKey
·
2 сағат бұрын
Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
Investing.com
·
4 сағат бұрын
Truist raises Amgen stock price target to $380 on pipeline growth
Yahoo Finance
·
5 сағат бұрын
Amgen (AMGN) Backs $30 Million Series A Round In AI Genetic Testing
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 мың
Founded1980
HeadquartersТаузенд-Оукс, Калифорния, Америка Құрама Штаттары
Sector-
Websiteamgen.com